TrialDiabetes, obesity & metabolism2014

Pharmacodynamics of the glucagon-like peptide-1 receptor agonist lixisenatide in Japanese and Caucasian patients with type 2 diabetes mellitus poorly controlled on sulphonylureas with/without metformin.

Y Seino et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.